Becton, Dickinson and Company (BD) has globally introduced the new automated instrument, the BD FACSDuet Premium Sample Preparation System, for cellular diagnostic applications.

Using liquid-handling robotics, the system will automate the complete sample preparation process for both in vitro diagnostics (IVD) and user-defined tests including cocktailing, washing and centrifuging.

Later, it will automatically shift samples to the physically integrated BD FACSLyric Clinical Flow Cytometry System without human support.

The integration of the flow cytometer with the BD FACSDuet facilitates the creation of a ‘walkaway’ workflow solution, which needs fewer manual steps and resources.

Flow cytometry, which is a critical tool for clinical diagnostics, is mostly used in the diagnosis and management of diseases such as cancer.

BD Biosciences worldwide president Steve Conly said: “Our clinical customers have long trusted BD and our best-in-class products to standardise every step of the clinical lab workflow – from panel creation to sample preparation to analysis to report.

“The flagship BD FACSLyric Flow Cytometry System is one of the fastest adopted clinical instruments in the world and now together with the FACSDuet Premium System, which has achieved IVD status in the US and Europe, we usher in greater levels of automation so that our customers can focus more of their valuable time on analysing and interpreting samples and impacting outcomes.”

Last month, BD obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its new artificial intelligence-powered software to diagnose Methicillin-resistant Staphylococcus aureus.